**Core Concept:** Opioid withdrawal syndrome is a set of physical and psychological symptoms that occur when an individual dependent on opioids stops or significantly reduces their intake. These symptoms are due to the body's attempt to return to its baseline homeostasis after the absence of the opioid's influence. Non-opioid medications can help alleviate some of these symptoms.

**Why the Correct Answer is Right:** The correct answer, clonidine (Option C), is a centrally acting alpha-2 adrenergic agonist, which helps to reduce symptoms of opioid withdrawal syndrome by increasing the release of norepinephrine and decreasing the release of dopamine and serotonin. This results in decreased sympathetic activity and reduced stimulation of the central nervous system.

**Why Each Wrong Option is Incorrect:**

A. Benzodiazepines (Option A) are centrally acting GABA agonists which would worsen the symptoms of opioid withdrawal syndrome. They work by enhancing the inhibitory neurotransmission in the central nervous system, which is counterproductive in this context.

B. Antihistamines (Option B) are peripherally acting H1 antagonists that would not effectively address the central nervous system symptoms of opioid withdrawal syndrome. They primarily modulate histamine activity in the peripheral nervous system and do not have a direct impact on the central symptoms of opioid withdrawal.

D. Promethazine (Option D) is an example of an antihistamine (as explained above) and would not be an appropriate choice for treating opioid withdrawal symptoms.

**Clinical Pearl:** In treating opioid withdrawal syndrome, clinicians should consider using benzodiazepines with supportive care, rather than relying on non-specific antihistamines like promethazine or other peripheral agents. Clonidine, a centrally acting alpha-2 agonist, is a more suitable option for alleviating opioid withdrawal symptoms.